Additionally, our observation of poor handgrip strength (a core frailty marker) in SCD-SG and MCI-SG subgroups reinforces prior links between IL-6, reduced muscle mass, and cognitive impairment (35, 36), but contextualizes this within preclinical AD—where intervention potential is greatest. This evidence concerns the gene IL6 and Alzheimer disease.